Let’s start up with the current stock price of Baudax Bio Inc. (BXRX), which is $0.80 to be very precise. The Stock rose vividly during the last session to $0.79 after opening rate of $0.7749 while the lowest price it went was recorded $0.7696 before closing at $0.78.
Recently in News on June 8, 2021, Baudax Bio’s ANJESO® Achieves Formulary Listing at Over 100 Institutions in Less Than One Year on the Market. Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, today announced that ANJESO® (meloxicam) injection has achieved approvals at over 100 formularies across the U.S. in under one year of commercialization. ANJESO’s presence on formularies is expected to drive usage through regular availability at both hospitals and ambulatory care centers covered by these formularies. You can read further details here
Baudax Bio Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.1200 on 02/09/21, with the lowest value was $0.7500 for the same time period, recorded on 05/11/21.
Baudax Bio Inc. (BXRX) full year performance was -80.35%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Baudax Bio Inc. shares are logging -83.12% during the 52-week period from high price, and 6.43% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.75 and $4.73.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1430206 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Baudax Bio Inc. (BXRX) recorded performance in the market was -23.17%, having the revenues showcasing -35.87% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 66.88M, as it employees total of 57 workers.
Analysts verdict on Baudax Bio Inc. (BXRX)
During the last month, 0 analysts gave the Baudax Bio Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.2396, with a change in the price was noted -0.52. In a similar fashion, Baudax Bio Inc. posted a movement of -39.39% for the period of last 100 days, recording 3,875,966 in trading volumes.
Baudax Bio Inc. (BXRX): Technical Analysis
Raw Stochastic average of Baudax Bio Inc. in the period of last 50 days is set at 8.26%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 26.43%. In the last 20 days, the company’s Stochastic %K was 16.38% and its Stochastic %D was recorded 17.05%.
Let’s take a glance in the erstwhile performances of Baudax Bio Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -23.17%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -37.42%, alongside a downfall of -80.35% for the period of the last 12 months. The shares increased approximately by -14.06% in the 7-day charts and went down by -6.67% in the period of the last 30 days. Common stock shares were lifted by -35.87% during last recorded quarter.